SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
Ziwu
Lv1
20 积分
2022-11-04 加入
最近求助
最近应助
互助留言
Perivascular Niche–Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment
16小时前
已完结
911 Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
16小时前
已完结
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials
15天前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
18天前
已完结
Prevalence by therapy line and incidence of breast cancer brain metastases in 18,075 patients
1个月前
已完结
A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumors
1个月前
已完结
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer
8个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
9个月前
已完结
Different dosage forms of GnRHa with endocrine therapy in premenopausal hormone Receptor-Positive breast cancer
10个月前
已完结
Validation of a predictive modeling approach to demonstrate the relative efficacy of three different schedules of the AKT inhibitor AZD5363
1年前
已完结
没有进行任何应助
感谢,速度真快
16小时前
感谢,速度真快
16小时前
速度真快,点赞
15天前
速度真快,点赞
18天前
非常感谢,等了2天终于有人帮忙下载了!
26天前
感谢,点赞
1个月前
感谢,速度真快
8个月前
点赞,感谢
9个月前
速度真快,点赞
10个月前
感谢,点赞,速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论